The preoperative cardiovascular evaluation of the intermediate-risk patient: New data, changing strategies

American Journal of Medicine

Volumn 118, Issue 12, 2005, Pages 1413.e1-1413.e9

  Wesorick, David H ^a,b   Eagle, Kim A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adrenergic beta antagonists; Exercise test; Myocardial revascularization; Perioperative care; Preoperative care; Risk assessment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; HEART MUSCLE REVASCULARIZATION; HUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW;

EID: 29244475361     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.07.068     Document Type: Review

References (49)

1. L. Goldman, D.L. Caldera, S.R. Nussbaum Multifactorial index of cardiac risk in noncardiac surgical procedures N Engl J Med 297 1977 845 850
2. A.S. Detsky, H.B. Abrams, J.R. McLaughlin Predicting cardiac complications in patients undergoing non-cardiac surgery J Gen Intern Med 1 1986 211 219
3. T.H. Lee, E.R. Marcantonio, C.M. Mangione Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery Circulation 100 1999 1043 1049
4. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). 2002. American College of Cardiology Web site. Available at: http:/www.acc.org/clinical/guidelines/perio/ dirIndex.htm. Accessed June 2004.
5. P.A. Grayburn, L.D. Hillis Cardiac events in patients undergoing noncardiac surgery shifting the paradigm from noninvasive risk stratification to therapy Ann Intern Med 138 2003 506 511
6. K.A. Eagle, C.M. Coley, J.B. Newell Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery Ann Intern Med 110 1989 859 866
7. G. Vanzetto, J. Machecourt, D. Blendea Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery Am J Cardiol 77 1996 143 148
8. E. Boersma, D. Poldermans, J.J. Bax Predictors of cardiac events after major vascular surgery role of clinical characteristics, dobutamine echocardiography, and B-blocker therapy JAMA 285 2001 1865 1873
9. E.D. Foster, K.B. Davis, J.A. Carpenter Risk of noncardiac operation in patients with defined coronary disease the coronary artery surgery study (CASS) registry experience Ann Thorac Surg 41 1986 42 49
10. K.A. Eagle, R.S. Charantjit, M.C. Mickel Cardiac risk of noncardiac surgery influence of coronary disease and type of surgery in 3368 operations Circulation 96 1997 1882 1887
11. E.O. McFalls, H.B. Ward, T.E. Moritz Coronary-artery revascularization before elective major vascular surgery N Engl J Med 351 2004 2795 2804
12. S.A. Hassan, M.A. Hlatky, D.B. Boothroyd Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the bypass angioplasty revascularization investigation (BARI) Am J Med 110 2001 260 266
13. G.L. Kaluza, J. Joseph, J.R. Lee Catastrophic outcomes of noncardiac surgery soon after coronary stenting J Am Coll Cardiol 35 2000 1288 1294
14. S.H. Wilson, P. Fasseas, J.L. Orford Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting J Am Coll Cardiol 42 2003 234 240
15. K.L. Posner, G.A. Van Norman, V. Chan Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty Anesth Analg 89 1999 553 560
16. M.R. Tamberella, M.I. Furman The role of platelet inhibition in the drug-eluting stent era Coron Artery Dis 15 2004 327 329
17. N.I. Muni, T.P. Gross Problems with drug-eluting coronary stents - the FDA perspective N Engl J Med 351 2004 1593 1595
18. J.W. Moses, M.B. Leon, J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
19. G.W. Stone, S.G. Ellis, D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
20. K.A. Eagle, R.A. Guyton, R. Davidoff ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines Circulation 100 1999 1464 1480
21. S.C. Smith, J.T. Dove, A.K. Jacobs ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 37 2001 2215 2238
22. L.L. Boland, A.R. Folsom, P.D. Sorlie Occurrence of unrecognized myocardial infarction in subjects aged 45-65 years (the ARIC study) Am J Cardiol 90 2002 927 931
23. Y. Almanaseer, D. Mukherjee, E.M. Kline-Rogers Implementation of the ACC/AHA Guidelines for Preoperative Cardiac Risk Assessment in a general medicine preoperative clinic improving efficiency and preserving outcomes Cardiology 103 2005 24 29
24. C. Bartels, J.F. Bechtel, V. Hossman, S. Horsch Cardiac risk stratification for high-risk vascular surgery Circulation 95 1997 2473
25. J.B. Froehlich, D. Karavite, P.L. Russman American College of Cardiology/American Heart Association preoperative assessment guidelines reduce resource utilization before aortic surgery J Vasc Surg 36 2002 758 763
26. M.M. Bodenheimer Noncardiac surgery in the cardiac patient what is the question? Ann Intern Med 124 1996 763
27. D.T. Mangano, E.L. Layug, A. Wallace Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery N Engl J Med 335 1996 1713 1720
28. A. Wallace, B. Layug, I. Tateo Prophylactic atenolol reduces postoperative myocardial ischemia Anesthesiology 88 1998 7 17
29. K.A. Eagle, J.B. Froelich Reducing cardiovascular risk in patients undergoing noncardiac surgery N Engl J Med 335 1996 1761 1763
30. D. Poldermans, E. Boersma, J.J. Bax The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery N Engl J Med 341 1999 1789
31. J.R. Levinson, C.A. Boucher, C.M. Colley Usefulness of semiquantitative analysis of dipyridimole-thallim-201 redistribution for improving risk stratification before vascular surgery Am J Cardiol 66 1990 406 410
32. P.K. Lindenauer, P. Pekow, K. Wang Perioperative beta-blocker therapy and mortality after major noncardiac surgery N Engl J Med 353 2005 349 361
33. The American College of Physicians Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery Ann Intern Med 127 1997 309 312
34. A.D. Auerbach, L. Goldman B-blockers and reduction of cardiac events in noncardiac surgery scientific review JAMA 287 2002 1435 1444
35. S.R. Salpeter, T.M. Ormiston, E.E. Salpeter Cardioselective B-blockers in patients with reactive airway disease a meta-analysis Ann Intern Med 137 2002 715 725
36. S.S. Salpeter, T.M. Ormiston, E.E. Salpeter Cardioselective beta-blockers for chronic obstructive pulmonary disease Cochrane Database Syst Rev 2003 3
37. A.D. Auerbach, L. Goldman B-blockers and reduction of cardiac events in noncardiac surgery clinical applications JAMA 287 2002 1445 1447
38. D.N. Wijeysundera, J.S. Naik, W.S. Beattie Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications a meta-analysis Am J Med 114 2003 742 752
39. R.D. Stevens, H. Burri, M.R. Tramer Pharmacologic myocardial protection in patients undergoing noncardiac surgery a quantitative systematic review Anesth Analg 97 2003 623 633
40. L. Goldman Evidence-based perioperative risk reduction Am J Med 114 2003 763 764
41. D.N. Wijeysundera, W.S. Beattie Cacium channel blockers for reducing cardiac morbidity after noncardiac surgery a meta-analysis Anesth Analg 97 2003 634 641
42. D. Poldermans, J.J. Bax, M.D. Kertai Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery Circulation 107 2003 1848 1851
43. P.K. Lindenauer, P. Pekow, K. Wang lipid-lowering therapy and in-hospital mortality following major noncardiac surgery JAMA 291 2004 2092 2099
44. A.E.S. Durazzo, F.S. Machado, D.T. Ikeoka Reduction in cardiovascular events after vascular surgery with atorvastatin a randomized trial J Vasc Surg 39 2004 967 976
45. The American College of Physicians Perioperative assessment and management of risk from coronary artery disease Ann Intern Med 127 1997 313 328
46. C.K. Morris, K. Ueshima, T. Kawaguchi The prognostic value of exercise capacity a review of the literature Am Heart J 122 1991 1423 1431
47. C.L. Nelson, J.E. Herndon, D.B. Mark Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index Am J Cardiol 68 1991 973 975
48. P. Older, B. Smith, P. Courtney, R. Hone Preoperative evaluation of cardiac failure and ischemia in elderly patients by cardiopulmonary exercise testing Chest 104 1993 701 704
49. D.F. Reilly, M.J. McNeely, D. Doerner Self-reported exercise tolerance and the risk of serious perioperative complications Arch Intern Med 159 1999 2185 2192